LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 96.35 USD 1.55% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note

Intrinsic Value

The intrinsic value of one LMAT stock under the Base Case scenario is 53.49 USD. Compared to the current market price of 96.35 USD, LeMaitre Vascular Inc is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LMAT Intrinsic Value
53.49 USD
Overvaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LeMaitre Vascular Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LMAT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LMAT?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about LeMaitre Vascular Inc

Provide an overview of the primary business activities
of LeMaitre Vascular Inc.

What unique competitive advantages
does LeMaitre Vascular Inc hold over its rivals?

What risks and challenges
does LeMaitre Vascular Inc face in the near future?

Has there been any significant insider trading activity
in LeMaitre Vascular Inc recently?

Summarize the latest earnings call
of LeMaitre Vascular Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LeMaitre Vascular Inc.

Provide P/S
for LeMaitre Vascular Inc.

Provide P/E
for LeMaitre Vascular Inc.

Provide P/OCF
for LeMaitre Vascular Inc.

Provide P/FCFE
for LeMaitre Vascular Inc.

Provide P/B
for LeMaitre Vascular Inc.

Provide EV/S
for LeMaitre Vascular Inc.

Provide EV/GP
for LeMaitre Vascular Inc.

Provide EV/EBITDA
for LeMaitre Vascular Inc.

Provide EV/EBIT
for LeMaitre Vascular Inc.

Provide EV/OCF
for LeMaitre Vascular Inc.

Provide EV/FCFF
for LeMaitre Vascular Inc.

Provide EV/IC
for LeMaitre Vascular Inc.

Show me price targets
for LeMaitre Vascular Inc made by professional analysts.

What are the Revenue projections
for LeMaitre Vascular Inc?

How accurate were the past Revenue estimates
for LeMaitre Vascular Inc?

What are the Net Income projections
for LeMaitre Vascular Inc?

How accurate were the past Net Income estimates
for LeMaitre Vascular Inc?

What are the EPS projections
for LeMaitre Vascular Inc?

How accurate were the past EPS estimates
for LeMaitre Vascular Inc?

What are the EBIT projections
for LeMaitre Vascular Inc?

How accurate were the past EBIT estimates
for LeMaitre Vascular Inc?

Compare the revenue forecasts
for LeMaitre Vascular Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LeMaitre Vascular Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LeMaitre Vascular Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of LeMaitre Vascular Inc compared to its peers.

Compare the P/E ratios
of LeMaitre Vascular Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing LeMaitre Vascular Inc with its peers.

Analyze the financial leverage
of LeMaitre Vascular Inc compared to its main competitors.

Show all profitability ratios
for LeMaitre Vascular Inc.

Provide ROE
for LeMaitre Vascular Inc.

Provide ROA
for LeMaitre Vascular Inc.

Provide ROIC
for LeMaitre Vascular Inc.

Provide ROCE
for LeMaitre Vascular Inc.

Provide Gross Margin
for LeMaitre Vascular Inc.

Provide Operating Margin
for LeMaitre Vascular Inc.

Provide Net Margin
for LeMaitre Vascular Inc.

Provide FCF Margin
for LeMaitre Vascular Inc.

Show all solvency ratios
for LeMaitre Vascular Inc.

Provide D/E Ratio
for LeMaitre Vascular Inc.

Provide D/A Ratio
for LeMaitre Vascular Inc.

Provide Interest Coverage Ratio
for LeMaitre Vascular Inc.

Provide Altman Z-Score Ratio
for LeMaitre Vascular Inc.

Provide Quick Ratio
for LeMaitre Vascular Inc.

Provide Current Ratio
for LeMaitre Vascular Inc.

Provide Cash Ratio
for LeMaitre Vascular Inc.

What is the historical Revenue growth
over the last 5 years for LeMaitre Vascular Inc?

What is the historical Net Income growth
over the last 5 years for LeMaitre Vascular Inc?

What is the current Free Cash Flow
of LeMaitre Vascular Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for LeMaitre Vascular Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
LeMaitre Vascular Inc

Current Assets 227.1m
Cash & Short-Term Investments 123.9m
Receivables 32.3m
Other Current Assets 71m
Non-Current Assets 149.9m
PP&E 41.1m
Intangibles 103.2m
Other Non-Current Assets 5.5m
Current Liabilities 29.3m
Accounts Payable 1.7m
Accrued Liabilities 26.2m
Other Current Liabilities 1.5m
Non-Current Liabilities 16.6m
Other Non-Current Liabilities 16.6m
Efficiency

Earnings Waterfall
LeMaitre Vascular Inc

Revenue
213m USD
Cost of Revenue
-67.5m USD
Gross Profit
145.6m USD
Operating Expenses
-96m USD
Operating Income
49.6m USD
Other Expenses
-8.3m USD
Net Income
41.3m USD

Free Cash Flow Analysis
LeMaitre Vascular Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LMAT Profitability Score
Profitability Due Diligence

LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
61/100
Profitability
Score

LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

LMAT Solvency Score
Solvency Due Diligence

LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LMAT Price Targets Summary
LeMaitre Vascular Inc

Wall Street analysts forecast LMAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LMAT is 98.26 USD with a low forecast of 85.85 USD and a high forecast of 110.25 USD.

Lowest
Price Target
85.85 USD
11% Downside
Average
Price Target
98.26 USD
2% Upside
Highest
Price Target
110.25 USD
14% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LMAT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 5, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for LMAT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LMAT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc

Country

United States of America

Industry

Health Care

Market Cap

2.2B USD

Dividend Yield

0.64%

Description

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

Contact

MASSACHUSETTS
Burlington
63 2nd Ave
+17812212266.0
www.lemaitre.com

IPO

2006-10-19

Employees

450

Officers

Chairman & CEO
Mr. George W. LeMaitre
President & Director
Mr. David B. Roberts
CFO, Secretary & Director
Mr. Joseph P. Pellegrino Jr.
Senior Vice President of Operations
Mr. Trent G. Kamke
Founder and Chairman of Scientific Advisory Board
Dr. George D. LeMaitre
Vice President of Marketing
Ms. Kimberly L. Cieslak
Show More
Senior Director of Human Resources
Mr. Daniel J. Mumford
Senior Vice President of Information Technology
Mr. Jonathan W. Ngau
Senior Vice President of Sales ? Central Europe
Mr. Maik D. Helmers
Senior Vice President of Advanced Manufacturing Engineering
Mr. Ryan H. Connelly
Show Less

See Also

Discover More
What is the Intrinsic Value of one LMAT stock?

The intrinsic value of one LMAT stock under the Base Case scenario is 53.49 USD.

Is LMAT stock undervalued or overvalued?

Compared to the current market price of 96.35 USD, LeMaitre Vascular Inc is Overvalued by 44%.

Back to Top